Roadkill study could speed detection of kidney cancer

January 27, 2009

Large-scale data mining of gene networks in fruit flies has led researchers to a sensitive and specific diagnostic biomarker for human renal cell carcinoma, the most common type of kidney cancer. In the journal Science, published early online January 22, a team based at the University of Chicago shows that the biomarker known as SPOP is produced by 99 percent of clear cell renal cell carcinomas but not by normal kidney tissue.

Physicians could use SPOP levels to confirm or rule out a diagnosis of renal cell carcinoma (RCC). It could also help them determine the original source of cancers that had spread to other organs from an unknown primary tumor.

"This could serve as a diagnostic tool, lead us to new drug targets and potentially help us detect kidney cancers sooner," said study-director Kevin White, PhD, professor of human genetics, and ecology and evolution, and director of the Institute for Genetics and Systems Biology at the University of Chicago. "It also confirms our strategy of using genomics and systems-level analysis of model organisms such as fruit flies to identify factors that play crucial roles in human disease."

The study began with the fly genome. White and colleagues, who study gene regulation-how genes or entire networks of genes get turned on of off-wanted to measure the downstream effects of two key genes, known as Eve and Ftz, that control early steps in the development of flies, beginning just after the eggs are laid.

Because Eve and Ftz regulate the activity of other genes, and many of those genes control the activity of additional genes, both had a large impact. Eve influences the expression of 1,074 different genes and Ftx impacts 1,310 genes.

When they narrowed their search to genes directly impacted, the total fell to 235 genes. About 20 percent of those target genes regulate transcription, the activation of other genes, and 40 percent controlled developmental processes.

About 150 of those target genes have human equivalents. When the researchers ranked those 150 genes according to their impact in flies, the top candidate was a gene known as CG9924, or Roadkill, the central player in a major hub of networked genes and a crucial component in the development of the nervous system. SPOP, the human equivalent, is about 80 percent identical to Roadkill.

Looking closer, they determined that SPOP appeared to play a role not just in development but also in human cancers. It interacts with cell signaling pathways-JNK and RAS-that frequently go awry in multiple human cancers.

At this point, the researchers shifted their focus from fly genetics to human cancer. When they screened hundreds of tissue samples from 18 different tumor types, acquired from patients having surgery, they found that 85 percent of renal cell carcinomas produced high amounts of SPOP, while normal kidney tissue was uniformly negative.

When they looked at 300 renal cell cancer samples, 77 percent were positive for SPOP. All normal kidney samples were negative.

About 75 percent of all renal cell cancers are clear cell RCC. The researchers found that 99 percent of the clear cell RCC samples showed evidence of elevated SPOP. The SPOP test even revealed that a few tumors had originally been misdiagnosed as clear cell RCC. Those turned out to be other types of kidney cancer when examined more closely by pathologists.

"These results indicate that SPOP is a highly sensitive and specific diagnostic biomarker for clear cell RCC," the authors conclude, "and can help distinguish histological subtypes of RCC."

It could also be used to help identify the primary tumor in metastatic cancers, important in treatment decisions.

University of Chicago Medical Center

---

---

	100 Questions & Answers About Kidney Cancer by Steven C. Campbell (Author), Brian I. Rini (Author), Robert G. Uzzo (Author), Brian Lane (Author) Empower Yourself! There Are Approximately 37,000 Cases Of Kidney (Renal Cell) Cancer In The US Each Year. Whether You're A Newly Diagnosed Cancer Patient, A Survivor, Or Loved One Of Someone Suffering From Kidney Cancer, This Book Offers Help. The Only Text Available To Provide Both The Doctor's And Patient's Views, 100 Questions & Answers About Kidney Cancer, Provides Practical, Authoritative Answers To 100 Of The Most Common Questions Asked By Cancer Patients And Survivors. Written With Commentary From Actual Patients, This Is An Invaluable Resource For Anyone Struggling With The Medical, Physical, And Emotional Turmoil Of This Disease.
	Johns Hopkins Patients' Guide to Kidney Cancer (Johns Hopkins Medicine) by Michael A. Carducci (Author) The Johns Hopkins Patients Guide to Kidney Cancer is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining kidney cancer treatments from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and provides valuable tools to help you to put together your plan of care. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	We Have Kidney Cancer by Kidney Cancer Association Written by experts affiliated with the Kidney Cancer Association, this book can help to save your life or the life of someone you love. Learn how to survive kidney cancer and find out about the latest surgical techniques and treatments for advanced disease (kidney cancer that has spread beyond the kidney to other parts of the body). Edited for the Kindle by Bill Bro, CEO of the Kidney Cancer Association.
	100 Questions & Answers About Kidney Cancer - Updated Edition by Steven C. Campbell (Author), Brian I. Rini (Author), Robert G. Uzzo (Author), Brian Lane (Author) Empower Yourself! Whether You're A Newly Diagnosed Patient, Survivor, Or Loved One Of Someone Suffering From Kidney Cancer, 100 Questions & Answers About Kidney Cancer - Updated Edition Offers Essential And Practical Guidance. Containing 26 Updated Questions And Answers, This Book Provides Both Doctor And Patient Viewpoints While Giving Authoritative Answers To The Most Common Questions Asked About Renal Cancer. Featuring Compelling Commentary From Actual Patients, 100 Questions & Answers About Kidney Cancer-Updated Edition Is An Invaluable Resource For Anyone Struggling With The Medical, Physical, And Emotional Challenges Of This Disease.
	What to Eat if You Have Cancer (revised): Healing Foods that Boost Your Immune System by Maureen Keane (Author), Daniella Chace (Author) Fuel your body to fight cancer Cancer and cancer treatment take a toll on your body, but you can help make cancer treatment more effective and reduce its unpleasant side effects with good nutrition. What to Eat if You Have Cancer presents the best foods to fight cancer and suggests ways to keep your body strong--knowledge you need to take control of your health. A vital resource for cancer patients, this revised edition contains new recipes, new menus, and the latest research on cancer and nutrition. With the help of What to Eat if You Have Cancer, you will learn The foods to eat and the foods to avoid in your fight with cancer The proper use of supplements in nutrition therapy How to create personalized meal plans to complement different types and phases...
	Cancer Wars Maars Journey by Hill Print Solutions In autumn of 1993, a then record, 20 pound kidney cancer that went metastatic to distant organs ambushed Gerald White at the peak of a successful scientific career. After 2 killer surgeries and 8 solid months of treatment failed, he was left to reckon with that dreaded pronouncement that every cancer patient dreads to hear; "There is nothing more we can do and you likely have 3 more months at most". Gerald actually told his doctor that, "If medical science cannot solve this problem , then engineering science will and I will not die in these three months!". Far too often cancer victims are in such shock by news like this that they just accept the diagnosis and give up. This book tells how Gerald set about to learn about the elements of the human immune system and how mind/body medicine,...
	Defeat Cancer: 15 Doctors of Integrative & Naturopathic Medicine Tell You How by Connie Strasheim (Author), 13 Cancer Doctors (Author), Richard Linchitz MD (Introduction), Robert Rowen MD (Introduction) ONE-ON-ONE WITH 15 CANCER DOCTORS: If you traveled the world for appointments with fifteen cancer doctors, you would discover many of the cutting-edge treatments used to heal the body from cancer. You would also spend thousands of dollars on hotels, plane tickets, and medical appointment fees-not to mention the time that it would take to embark on such a journey. Even if you had the time and money to travel, would the physicians have enough time to answer all of your questions? Would you even know which questions to ask? In this long-awaited book, health care journalist Connie Strasheim has done all the work for you. She conducted intensive interviews with fifteen highly regarded doctors who specialize in cancer treatment, asking them thoughtful, important...
	Kidney Cancer: Your Way Forward by Abaco Publishing You will never cure anything if you don’t do something about the underlying cause. This applies to every illness including kidney cancer. In my book ‘Kidney Cancer – Your way forward’ I explain why it may have developed, giving you something to do to change the underlying causes and bring things under control. It is likely to be something you are passing through your kidneys. It could be helped by bad eating habits, a poor immune system, infections, too many antibiotics, toxic chemicals, geopathic stress and certainly stresses of everyday life affecting your emotions. When cancer declares itself, it could have been developing for ten or fifteen years. All of this is explained to you in detail as though you are with me in my consulting room. I then give ideas on how to change your...
	The Textbook of Kidney Cancer by Inderbir S. Gill (Editor), Michael B Atkins (Editor), Arie Belldegrun (Editor) The main purpose of this book is to produce a fully comprehensive textbook of the whole subject of kidney cancer, providing theoretical and practical knowledge for both the basic researcher and also the clinical practitioner. In this way, the hope is to produce the definitive text in the field, wherein the theoretical basis of molecular, genetic, and patho-physiologic aspects will precede the practical aspects of surgical and medical-oncologic therapy. Unquestionably, at the time of writing, the contemporary management of kidney cancer is a hot topic in urologic oncology and it is this constantly evolving landscape which is the primary driving force underpinning the writing of this project now. Contemporary clinical management of patients with kidney cancer requires a clear...
	Kidney Cancer: Principles and Practice by Primo N. Lara Jr. (Editor), Eric Jonasch (Editor) This interdisciplinary textbook encompasses all clinically relevant aspects of the disease and is designed to be as user-friendly as possible in order to meet the needs of the busy practitioner. To this end, the informative text is complemented by helpful boxed sections that present essential ‘take home’ points and illustrative patient-oriented cases. Original high-quality images, some in color, are included whenever necessary to simplify particularly complex material. The authors are an international group of acknowledged experts in kidney cancer epidemiology, molecular biology, pathology, diagnosis, clinical features, staging, prognostic and predictive factors, surgery, systemic therapy, and emerging investigational approaches, among others. This clinically oriented volume will be...